Occupational therapy in multiple system atrophy: a pilot randomized controlled trial

Movement Disorders : Official Journal of the Movement Disorder Society
Shilpa JainE Diane Playford

Abstract

There is some evidence that rehabilitation therapies may be useful in progressive neurological conditions, but this usefulness has not been studied in multiple system atrophy (MSA) to date. The aim of this small pilot study was to identify the feasibility of a larger randomized controlled trial of occupational therapy and to report preliminary data on the impact of occupational therapy on disability, mood, and health-related quality of life in patients with MSA. Patient groups were comparable for age, gender distribution, type of MSA, and severity. The active occupational therapy intervention group experienced a significant reduction of Unified Parkinson's Disease Rating Scale (total score and Activities of Daily Living [ADL] section), and PDQ-39 scores (total scores and ADL subsection). An occupational therapy program may improve functional abilities in patients with mild to moderate MSA. A larger multicenter study is needed.

References

Jun 1, 1987·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·L GauthierS Gauthier
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Jun 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·V PetoR Greenhall
Aug 1, 1994·Brain : a Journal of Neurology·G K WenningN P Quinn
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·P Martínez-MartínF Bermejo
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·J J van HiltenR A Roos
Oct 1, 1996·Archives of Physical Medicine and Rehabilitation·K D HillS J Gibson
Dec 17, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·R FitzpatrickN Hyman
Jun 5, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·E A ChrischillesR L Rodnitzky
Sep 12, 2000·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A M DamianoE D Means
Feb 13, 2001·Postgraduate Medical Journal·S W ParryJ Bond
Feb 8, 2002·Journal of Psychosomatic Research·Ingvar BjellandDag Neckelmann
Apr 30, 2002·Canadian Journal of Occupational Therapy. Revue Canadienne D'ergothérapie·Paula Gaudet
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·François TisonGregor K Wenning
Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Katherine H O DeaneCarl E Clarke
Dec 7, 2002·Clinical Neuropharmacology·Johan MarinusJacobus J van Hilten
Jan 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·D T WadeJ Kaye
Oct 7, 2003·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·Mary Egan, Jill Swedersky

❮ Previous
Next ❯

Citations

Apr 21, 2007·Current Treatment Options in Neurology·Christine D Esper, Stewart A Factor
May 28, 2009·Journal of Neurology·Gregor K Wenning, Nadia Stefanova
Aug 19, 2011·BMC Medical Research Methodology·Milensu ShanyindeMark Weatherall
Jan 15, 2015·The New England Journal of Medicine·Alessandra Fanciulli, Gregor K Wenning
Apr 15, 2014·Lancet Neurology·Ingrid H W M SturkenboomUNKNOWN OTiP study group
Oct 31, 2006·Parkinsonism & Related Disorders·A SchragN Quinn
Feb 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Ashwini K Rao
Oct 16, 2013·Zeitschrift für Gerontologie und Geriatrie·S Voigt-RadloffM Hüll
Mar 18, 2017·Nature Reviews. Neurology·Florian Krismer, Gregor K Wenning
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·Olivier FlabeauFrançois Tison
Aug 8, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Ana Castro CaldasUNKNOWN Movement Disorders Society MSA Study Group
Jul 20, 2007·The Cochrane Database of Systematic Reviews·L DixonK H O Deane
Feb 2, 2015·Movement Disorders Clinical Practice·Santiago Perez-LloretWassilios G Meissner
Aug 9, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Matthew R Burns, Nikolaus R McFarland
Jan 23, 2021·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·Yuma SonodaMakoto Urushitani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.